Publications
2024 Publications
Alimujiang A, Strecher V, McLean K, Mondul AM, Pearce CL, Mukherjee B. Decomposing
the association of psychosocial wellbeing with all-cause mortality: the mediating
role of physical health and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol.
2024 Jul 23. doi: 10.1007/s00127-024-02717-y. Epub ahead of print. PMID: 39044017.
Nagle CM, Ibiebele TI, Bandera EV, Cramer D, Doherty JA, Giles GG, Goodman MT, Hanley
GE, Harris HR, Jensen A, Kjaer SK, Lee AW, Milne RL, Qin B, Richardson J, Sasamoto
N, Sieh W, Terry KL, Titus L, Trabert B, Wentzensen N, Wu AH, Berchuck A, Pike M,
Pearce CL, Webb PM. Pre-diagnosis tea and coffee consumption and survival after a
diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium.
Br J Cancer. 2024 Oct;131(6):1043-1049. doi: 10.1038/s41416-024-02792-7. Epub 2024
Jul 18. PMID: 39026080; PMCID: PMC11405517.
Salvatore M, Kundu R, Shi X, Friese CR, Lee S, Fritsche LG, Mondul AM, Hanauer D,
Pearce CL, Mukherjee B. To weight or not to weight? The effect of selection bias in
3 large electronic health record-linked biobanks and recommendations for practice.
J Am Med Inform Assoc. 2024 Jun 20;31(7):1479-1492. doi: 10.1093/jamia/ocae098. PMID:
38742457; PMCID: PMC11187425.
Khoja L, Torres HG, Hak L, Aljebori M, Phung MT, Sakleh A, Stiffler M, Tariq M, Pearce
CL. Cervical cancer screening and vaccination acceptability and attitudes among Arab
American women in Southeastern Michigan: a qualitative study. Sci Rep. 2024 Jun 13;14(1):13624.
doi: 10.1038/s41598-024-64462-1. PMID: 38871762; PMCID: PMC11176183.
Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, Dezem FS, Seo
JH, Nameki R, Reyes AL, Aben KKH, Anton-Culver H, Antonenkova NN, Aravantinos G, Bandera
EV, Beane Freeman LE, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernardini MQ, Bjorge
L, Black A, Bogdanova NV, Bolton KL, Brenton JD, Budzilowska A, Butzow R, Cai H, Campbell
I, Cannioto R, Chang-Claude J, Chanock SJ, Chen K, Chenevix-Trench G; AOCS Group;
Chiew YE, Cook LS, DeFazio A, Dennis J, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles
DM, Ene G, Fasching PA, Flanagan JM, Fortner RT, Fostira F, Gentry-Maharaj A, Giles
GG, Goodman MT, Gronwald J, Haiman CA, Håkansson N, Heitz F, Hildebrandt MAT, Høgdall
E, Høgdall CK, Huang RY, Jensen A, Jones ME, Kang D, Karlan BY, Karnezis AN, Kelemen
LE, Kennedy CJ, Khusnutdinova EK, Kiemeney LA, Kjaer SK, Kupryjanczyk J, Labrie M,
Lambrechts D, Larson MC, Le ND, Lester J, Li L, Lubiński J, Lush M, Marks JR, Matsuo
K, May T, McLaughlin JR, McNeish IA, Menon U, Missmer S, Modugno F, Moffitt M, Monteiro
AN, Moysich KB, Narod SA, Nguyen-Dumont T, Odunsi K, Olsson H, Onland-Moret NC, Park
SK, Pejovic T, Permuth JB, Piskorz A, Prokofyeva D, Riggan MJ, Risch HA, Rodríguez-Antona
C, Rossing MA, Sandler DP, Setiawan VW, Shan K, Song H, Southey MC, Steed H, Sutphen
R, Swerdlow AJ, Teo SH, Terry KL, Thompson PJ, Vestrheim Thomsen LC, Titus L, Trabert
B, Travis R, Tworoger SS, Valen E, Van Nieuwenhuysen E, Edwards DV, Vierkant RA, Webb
PM; OPAL Study Group; Weinberg CR, Weise RM, Wentzensen N, White E, Winham SJ, Wolk
A, Woo YL, Wu AH, Yan L, Yannoukakos D, Zeinomar N, Zheng W, Ziogas A, Berchuck A,
Goode EL, Huntsman DG, Pearce CL, Ramus SJ, Sellers TA; Ovarian Cancer Association
Consortium (OCAC); Freedman ML, Lawrenson K, Schildkraut JM, Hazelett D, Plummer JT,
Kar S, Jones MR, Pharoah PDP, Gayther SA. Integrative multi-omics analyses to identify
the genetic and functional mechanisms underlying ovarian cancer risk regions. Am J
Hum Genet. 2024 Jun 6;111(6):1061-1083. doi: 10.1016/j.ajhg.2024.04.011. Epub 2024
May 8. PMID: 38723632; PMCID: PMC11179261.
Meagher NS, White KK, Wilkens LR, Bandera EV, Berchuck A, Carney ME, Cramer DW, Cushing-Haugen
KL, Jordan S, Kaufmann SH, Le ND, Pike MC, Riggan M, Qin B, Rothstein JH, Titus L,
Winham SJ, Anton-Culver H, Doherty JA, Goode EL, Pearce CL, Risch HA, Webb PM, Cook
LS, Goodman MT, Harris HR, Le Marchand L, McGuire V, Pharoah PDP, Sarink D, Schildkraut
JM, Sieh W, Terry KL, Thompson PJ, Whittemore AS, Wu AH, Peres LC, Merritt MA. Racial
and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian
Cancer Association Consortium. Am J Epidemiol. 2024 Sep 3;193(9):1242-1252. doi: 10.1093/aje/kwae076.
PMID: 38775277; PMCID: PMC11369223.
Khoja L, Wang Y, Haque SE, Ahsan H, Islam T, Munshi SU, Hasan AKMR, Islam MT, Jharna
AB, Pearce CL. Understanding of cervical cancer, acceptability of HPV self-collection,
and prevalence of HPV in a semi-urban setting in Bangladesh. PLOS Glob Public Health.
2024 Apr 24;4(4):e0003157. doi: 10.1371/journal.pgph.0003157. PMID: 38656991; PMCID:
PMC11042693.
Beddows I, Fan H, Heinze K, Johnson BK, Leonova A, Senz J, Djirackor S, Cho KR, Pearce
CL, Huntsman DG, Anglesio MS, Shen H. Cell State of Origin Impacts Development of
Distinct Endometriosis-Related Ovarian Carcinoma Histotypes. Cancer Res. 2024 Jan
2;84(1):26-38. doi: 10.1158/0008-5472.CAN-23-1362. PMID: 37874327; PMCID: PMC10758692.
2023 Publications
Heinze K, Cairns ES, Thornton S, et al. The Prognostic Effect of Immune Cell Infiltration
Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. Clin Cancer Res.
2023 Sep 1;29(17):3471-3483. doi: 10.1158/1078-0432.CCR-22-3815
Kang EY, Weir A, Meagher NS, et al. CCNE1 and survival of patients with tubo-ovarian
high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Cancer.
2023 Mar 1;129(5):697-713. doi: 10.1002/cncr.34582
2022 Publications
Meagher NS, Hamilton P, Milne K, et al. Profiling the immune landscape in mucinous
ovarian carcinoma. Gynecol Oncol. 2023;168:23-31. doi:10.1016/j.ygyno.2022.10.022
Garsed DW, Pandey A, Fereday S, et al. The genomic and immune landscape of long-term
survivors of high-grade serous ovarian cancer. Nat Genet. 2022;54(12):1853-1864. doi:10.1038/s41588-022-01230-9
Phung MT, Webb PM, DeFazio A, et al. Lifestyle and personal factors associated with
having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.
Gynecol Oncol. 2023;168:68-75. doi:10.1016/j.ygyno.2022.10.018
Phung MT, Alimujiang A, Berchuck A, et al. Reproductive Factors Do Not Influence Survival
with Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(4):909-913. doi:10.1158/1055-9965.EPI-21-1091
2021 Publications
Brieger KK, Phung MT, Mukherjee B, et al. High Prediagnosis Inflammation-Related Risk
Score Associated with Decreased Ovarian Cancer Survival. Cancer Epidemiol Biomarkers
Prev. 2022;31(2):443-452. doi:10.1158/1055-9965.EPI-21-0977
Hanley GE, Kaur P, Berchuck A, et al. Cardiovascular medications and survival in people
with ovarian cancer: A population-based cohort study from British Columbia, Canada.
Gynecol Oncol. 2021;162(2):461-468. doi:10.1016/j.ygyno.2021.05.021
2020 Publications
Saner FAM, Herschtal A, Nelson BH, et al. Going to extremes: determinants of extraordinary
response and survival in patients with cancer. Nat Rev Cancer. 2019;19(6):339-348.
doi:10.1038/s41568-019-0145-5
Millstein J, Budden T, Goode EL, et al. Prognostic gene expression signature for high-grade
serous ovarian cancer. Ann Oncol. 2020;31(9):1240-1250. doi:10.1016/j.annonc.2020.05.019
Brieger KK, Peterson S, Lee AW, et al. Menopausal hormone therapy prior to the diagnosis
of ovarian cancer is associated with improved survival. Gynecol Oncol. 2020;158(3):702-709.
doi:10.1016/j.ygyno.2020.06.481
2019 Publications
Minlikeeva AN, Cannioto R, Jensen A, et al. Joint exposure to smoking, excessive weight,
and physical inactivity and survival of ovarian cancer patients, evidence from the
Ovarian Cancer Association Consortium. Cancer Causes Control. 2019;30(5):537-547.
doi:10.1007/s10552-019-01157-3
Clarke CL, Kushi LH, Chubak J, et al. Predictors of Long-Term Survival among High-Grade
Serous Ovarian Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2019;28(5):996-999.
doi:10.1158/1055-9965.EPI-18-1324
Alimujiang A, Khoja L, Wiensch A, et al. "I am not a statistic" ovarian cancer survivors'
views of factors that influenced their long-term survival. Gynecol Oncol. 2019;155(3):461-467.
doi:10.1016/j.ygyno.2019.10.007
2017 Publications
Praestegaard C, Jensen A, Jensen SM, et al. Cigarette smoking is associated with adverse
survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
Int J Cancer. 2017;140(11):2422-2435. doi:10.1002/ijc.30600
Dixon SC, Nagle CM, Wentzensen N, et al. Use of common analgesic medications and ovarian
cancer survival: results from a pooled analysis in the Ovarian Cancer Association
Consortium. Br J Cancer. 2017;116(9):1223-1228. doi:10.1038/bjc.2017.68
Minlikeeva AN, Freudenheim JL, Eng KH, et al. History of Comorbidities and Survival
of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.
Cancer Epidemiol Biomarkers Prev. 2017;26(9):1470-1473. doi:10.1158/1055-9965.EPI-17-0367
Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium
Members of the EWG SC, in alphabetical order:, Doherty JA, Jensen A, et al. Current
Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. J
Natl Cancer Inst. 2017;109(10):djx144. doi:10.1093/jnci/djx144
2016 Publications
Cannioto RA, LaMonte MJ, Kelemen LE, et al. Recreational physical inactivity and mortality
in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer
Association Consortium. Br J Cancer. 2016;115(1):95-101. doi:10.1038/bjc.2016.153
2015 Publications
Nagle CM, Dixon SC, Jensen A, et al. Obesity and survival among women with ovarian
cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer. 2015;113(5):817-826.
doi:10.1038/bjc.2015.245